Micafungin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Xellia Pharmaceuticals Usa Llc. The primary component is Micafungin Sodium.
| Product ID | 70594-036_8305f19a-1419-4e4e-8884-e12b213e64ab |
| NDC | 70594-036 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Micafungin |
| Generic Name | Micafungin Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-05-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211713 |
| Labeler Name | Xellia Pharmaceuticals USA LLC |
| Substance Name | MICAFUNGIN SODIUM |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Echinocandin Antifungal [EPC],Lipopeptides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2021-06-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| MICAFUNGIN SODIUM | 10 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9361 | Micafungin | Micafungin sodium |
| 0143-9362 | Micafungin | Micafungin sodium |
| 16714-164 | Micafungin | Micafungin |
| 16714-301 | Micafungin | Micafungin |
| 25021-190 | Micafungin | Micafungin Sodium |
| 25021-191 | Micafungin | Micafungin Sodium |
| 42023-229 | Micafungin | Micafungin |
| 42023-230 | Micafungin | Micafungin |
| 60505-6119 | Micafungin | Micafungin |
| 60505-6120 | Micafungin | Micafungin |
| 63323-728 | Micafungin | Micafungin Sodium |
| 63323-729 | Micafungin | Micafungin Sodium |
| 70594-036 | Micafungin | Micafungin Sodium |
| 70594-037 | Micafungin | Micafungin Sodium |
| 71288-028 | Micafungin | Micafungin sodium |
| 71288-029 | Micafungin | Micafungin sodium |
| 72572-427 | Micafungin | Micafungin sodium |
| 0469-3211 | Mycamine | Micafungin Sodium |
| 0469-3250 | Mycamine | Micafungin Sodium |